Délais de prise en charge des quatre cancers les plus fréquents dans plusieurs régions de France en 2011 et 2012

Pourcel, G.; Ledésert, Bernard; Bousquet, Philippe‐Jean; Ferrari, Claudia; Viguier, Jérôme; Buzyn, Agnès

doi:10.1684/bdc.2013.1832

Cited by 18 publications

(8 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…For treatment WT, the main factor influencing longer access to care common to the different studies was the type of establishment for first treatment: public versus private. 8,16,28 Moreover, MRI use resulted in longer overall WTs in our study, as in two North American studies, 14,29 possibly due to limited availability of MRI machines. Indeed, several recommended practices (MDM, biopsy, MRI, reference centers) are time consuming but necessary for better quality treatment.…”

Section: Relations Of Other Factors To Wtsupporting

confidence: 56%

“…However, for most women, recommendations for good practice advocate for pathological and immuno‐histochemical diagnoses in order to better plan high quality treatment. For treatment WT, the main factor influencing longer access to care common to the different studies was the type of establishment for first treatment: public versus private . Moreover, MRI use resulted in longer overall WTs in our study, as in two North American studies, possibly due to limited availability of MRI machines.…”

Section: Discussionmentioning

confidence: 60%

“…In a 2003 French study, these WTs were 7 days and 27 days, respectively. 16 In another study piloted by the French National Cancer Institute in 2011, 8 the median time interval was 13 days from mammography to pathologist diagnosis and 21 days from diagnosis (or treatment proposal) to surgery. The median WT in the present study was situated between these two French studies and a Canadian study, 14 which found a median of 10 days for WT between first diagnostic imaging test to first biopsy, then a median of 4 days for WT between the first biopsy and the pathological diagnosis report and a median of 33 days for WT from pathological diagnosis to first surgery.…”

Section: Comparisons With Wts Reported In the Literaturementioning

confidence: 99%

“…Moreover, measuring WT could reveal inequalities in access to cancer care . Other links with socio‐economic status have already been shown with stage at diagnosis and mortality: poorer BC prognosis with advanced disease at diagnosis and increased risk of BC mortality were related to socio‐economic status .…”

mentioning

confidence: 98%

See 3 more Smart Citations

Are disparities of waiting times for breast cancer care related to socio‐economic factors? A regional population‐based study (France)

Ayrault-Piault

Grosclaude

Daubisse‐Marliac

et al. 2016

Intl Journal of Cancer

View full text Add to dashboard Cite

The increasing number of breast cancer cases may induce longer waiting times (WT), which can be a source of anxiety for patients and may play a role in survival. The aim of this study was to examine the factors, in particular socio-economic factors, related to treatment delays. Using French Cancer Registry databases and self-administered questionnaires, we included 1,152 women with invasive non-metastatic breast cancer diagnosed in 2007. Poisson regression analysis was used to identify WTs' influencing factors. For 973 women who had a malignant tissue sampling, the median of overall WT between the first imaging procedure and the first treatment was 44 days (9 days for pathological diagnostic WT and 31 days for treatment WT). The medical factors mostly explained inequalities in WTs. Socio-economic and behavioral factors had a limited impact on WTs except for social support which appeared to be a key point. Better identifying the factors associated with increase in WTs will make it possible to develop further interventional or prospective studies to confirm their causal role in delay and at last reduce disparities in breast cancer management.

show abstract

Section: Relations Of Other Factors To Wtsupporting

confidence: 56%

Section: Discussionmentioning

confidence: 60%

Section: Comparisons With Wts Reported In the Literaturementioning

confidence: 99%

mentioning

confidence: 98%

See 2 more Smart Citations

Are disparities of waiting times for breast cancer care related to socio‐economic factors? A regional population‐based study (France)

Ayrault-Piault

Grosclaude

Daubisse‐Marliac

et al. 2016

Intl Journal of Cancer

View full text Add to dashboard Cite

show abstract

“…Hence, a Canadian retrospective study evaluating more than 60 000 patients described a median time from first examination to surgery of 52 days (Cordeiro et al , 2015). In France, the National Cancer Institute described a 23-day median time from diagnosis or the multidisciplinary meeting therapeutic decision and treatment, with important regional disparities (Pourcel et al , 2013). Moreover, which threshold should be considered for each waiting time?…”

Section: Discussionmentioning

confidence: 99%

Preoperative clinical pathway of breast cancer patients: determinants of compliance with EUSOMA quality indicators

et al. 2017

View full text Add to dashboard Cite

Background:The European Society of Breast Cancer Specialists (EUSOMA) has defined quality indicators for breast cancer (BC). The aim of this study was to describe the preoperative clinical pathway of breast cancer patients and evaluate the determinants of compliance with EUSOMA quality indicators in the Optisoins01 cohort.Methods:Optisoins01 is a prospective, multicentric study. Data from operable BC patients were collected, including results from before surgery to 1 year follow-up. Seven preoperative EUSOMA quality indicators were compared with the clinical pathways Optisoins01.Results:Six hundred and four patients were included. European Society of Breast Cancer Specialists targets were reached for indicator 1 (completeness of clinical and imaging diagnostic work-up), 3 (preoperative definitive diagnosis) and 5 (waiting time). For indicator 8 (multidisciplinary discussion), the minimum standard of 90% of the patients was reached only in general hospitals and comprehensive cancer centres. Having more than 1 medical examination within the centre was associated with an increased waiting time for surgery, whereas it was reduced by having an outpatient breast biopsy. The comprehensive cancer centre type was the only parameter associated with the other quality indicators.Conclusions:European Society of Breast Cancer Specialists quality indicators are a useful tool to evaluate care organisations. This study highlights the need for a standardised and coordinated preoperative clinical pathway.

show abstract

Impact of an intervention on waiting times in the surgical pathway of women with breast cancer: a quasi-experimental study

Meriam,

Latifa,

Imen

et al. 2023

J Public Health (Berl.)

View full text Add to dashboard Cite

Délais de prise en charge des quatre cancers les plus fréquents dans plusieurs régions de France en 2011 et 2012

Cited by 18 publications

References 10 publications

Are disparities of waiting times for breast cancer care related to socio‐economic factors? A regional population‐based study (France)

Are disparities of waiting times for breast cancer care related to socio‐economic factors? A regional population‐based study (France)

Preoperative clinical pathway of breast cancer patients: determinants of compliance with EUSOMA quality indicators

Impact of an intervention on waiting times in the surgical pathway of women with breast cancer: a quasi-experimental study

Contact Info

Product

Resources

About